Clinical Trials on Sanofi – GSK Vaccine for COVID-19: Update
Combating the Corona virus through various means are underway. Development of COVID Vaccine by prominent pharmaceutical companies are in progress. The Vaccine (ClinicalTrials.gov Identifier: NCT04537208) being developed in collaboration with Sanofi and GSK has passed the pre-clinical trials and planned to begin its Phase I/II trials in the United States of America. They are expecting … Continue reading